Abstract:Cancer remains a global health challenge with high prevalence and mortality rates, imposing significant financial and emotional burdens on affected families. However, hope lies in genetic manipulation, with a focus on innovative approaches to combat genetically linked cancers. Clustered regularly interspaced short palindromic repeats (CRISPR), an adaptive immune system found in various bacteria and archaea, hold immense potential. We searched articles on PubMed Central, Medline, and PubMed databases indexed journals. The keywords from the research topic, i.e., "CRISPR AND genetic therapy," were searched, and we found 3397 articles. Following this, we explored the medical subject headings (MeSH) glossary and created a search strategy "Clustered Regularly Interspaced Short Palindromic Repeats"[Mesh] AND "Genetic Therapy"[Majr] and after applying a variety of filters we included 30 studies in our review. CRISPR consists of unique spacers and CRISPR-associated (Cas) genes, operating through acquisition, CRISPR ribonucleic acid (crRNA) biogenesis, and target interference phases. The type II CRISPR-Cas9 system is a well-researched avenue for gene editing, with Cas9 cleaving specific genomic regions and initiating deoxyribonucleic acid (DNA) repair mechanisms. Cancer results from genetic alterations, leading to tumor development with properties like metastasis. CRISPR/Cas9 offers precise genome editing to inhibit tumor formation by removing specific genomic sequences and promoting DNA repair. Challenges in CRISPR's use for cancer therapy, including delivery methods, cell adaptation, and ethical concerns, are recognized. Beyond cancer, CRISPR finds diverse applications in infectious diseases and non-cancerous conditions, signifying its transformative potential in modern medicine. CRISPR technology represents a groundbreaking frontier in cancer therapy and beyond, offering insights into genetic editing, disease mechanisms, and potential cures. Despite challenges and ethical considerations, precise genome editing promises improved cancer treatments and innovative medical interventions in the future.

Exploring Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-Associated Protein 9 (CRISPR-Cas9) as a Therapeutic Modality for Cancer: A Scoping Review

Applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) as a Genetic Scalpel for the Treatment of Cancer: A Translational Narrative Review

Engineering CRISPR/Cas9 therapeutics for cancer precision medicine

CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool

CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope

A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment

CRISPR/Cas9: an overview of recent developments and applications in cancer research

CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy

CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics

The role of the CRISPR‐Cas system in cancer drug development: Mechanisms of action and therapy

CRISPR/Cas9: A powerful genome editing technique for the treatment of cancer cells with present challenges and future directions

Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research

Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling

Application of CRISPR-Cas 9 system in cancer therapy

The Potential Revolution of Cancer Treatment with CRISPR Technology

Advances in targeting cancer epigenetics using CRISPR-dCas9 technology: A comprehensive review and future prospects

Current applications and future perspective of CRISPR/Cas9 gene editing in cancer

Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy

Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics

CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy